AbCellera Biologics Inc.
ABCL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$162,857 | -$146,398 | $158,519 | $153,464 |
| Dep. & Amort. | $96,998 | $30,894 | $33,102 | $17,250 |
| Deferred Tax | $0 | $1,960 | -$2,114 | -$2,018 |
| Stock-Based Comp. | $67,581 | $64,183 | $49,481 | $0 |
| Change in WC | -$25,843 | $13,225 | $29,825 | $41,672 |
| Other Non-Cash | -$84,435 | -$7,741 | $8,547 | $34,216 |
| Operating Cash Flow | -$108,556 | -$43,877 | $277,360 | $244,584 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$78,396 | -$77,507 | -$72,660 | -$58,452 |
| Net Acquisitions | -$19,626 | -$13,690 | -$25,679 | -$11,457 |
| Inv. Purchases | -$765,086 | -$1,066,159 | -$781,351 | -$322,567 |
| Inv. Sales/Matur. | $948,809 | $910,937 | $510,631 | $27,608 |
| Other Inv. Act. | $35,708 | $25,311 | $16,434 | $32,621 |
| Investing Cash Flow | $121,409 | -$221,108 | -$352,625 | -$332,247 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $13,498 | $11,590 | $2,755 | -$951 |
| Stock Issued | $0 | $0 | $0 | $4,615 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$729 | -$1,234 | -$4,383 | -$7,550 |
| Financing Cash Flow | $12,769 | $10,356 | -$1,628 | -$3,886 |
| Forex Effect | -$2,617 | $589 | -$9,599 | -$1,425 |
| Net Chg. in Cash | $23,005 | -$254,040 | -$86,492 | -$92,974 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $160,610 | $414,650 | $501,142 | $594,116 |
| End Cash | $183,615 | $160,610 | $414,650 | $501,142 |
| Free Cash Flow | -$186,952 | -$121,384 | $204,700 | $186,132 |